[14]
Astra and Takeda argue that they are entitled to the increased scale of costs when regard is had to the result of the proceeding, the importance and complexity of the issues and the amount or volume of work. I begin by stating that this was not a patent infringement or validity action. It was an application for an order of prohibition. Thus, the evidence was filed by way of affidavit and the issue for determination was whether the generic company was justified in its allegations of non-infringement or invalidity. It is intended that such matters be dealt with summarily.